Design of Potent, Selective, and Orally Bioavailable Inhibitors of Cysteine Protease Cathepsin K
Francis X. Tavares, Virginia M. Boncek, David N. Deaton et al. · Journal of Medicinal Chemistry · 2003
Osteoclast-mediated bone matrix resorption has been attributed to cathepsin K, a cysteine protease of the papain family that is abundantly and selectively expressed in osteoclast. Inhibition of cathepsin K could potentially be an effective method to prevent osteoporosis. Structure-activity studies on a series of reversible ketoamides based inhibitors of cathepsin K have led to identification of potent and selective compounds. Crystallographic studies have given insights into the mode of binding of these inhibitors. A series of ketoamides with varying P1 moieties were first synthesized to find an optimum group that would fit into the S1 subsite of the cysteine protease, cathepsin K. With a desired P1 group in place a variety of heterocyclic analogues in the P' region were synthesized to study their steric and electronic effects. In the process of exploring these P' heterocyclic variations, excellent selectivity was gained over other highly homologous cysteine proteases, including cathepsins L, S, and V. The favorable pharmacokinetic properties of some of these cathepsin K inhibitors in rats make them suitable for evaluation in rodent osteoporosis models. A representative cathepsin K inhibitor was shown to attenuate PTH-stimulated hypercalcemia in the TPTX rat model. These inhibitors provide a viable lead series in the discovery of new therapies for the prevention and treatment of osteoporosis
Cited by 45 works. doi:10.1021/jm030373l
Authors
- Francis X. Tavares
- Virginia M. Boncek
- David N. Deaton
- Anne M. Hassell
- Stacey T. Long
- Aaron B. Miller
- Alan A. Payne
- Larry R. Miller
- Lisa M. Shewchuk
- Kevin J. Wells‐Knecht
- Derril H. Willard
- Lois L. Wright
- Huiqiang Zhou
References
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
- Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization
- Protease Inhibitors: Current Status and Future Prospects
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts
- Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice
- Lysosomal cysteine proteases: more than scavengers
- Lysosomal cysteine proteases: facts and opportunities
- Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
- Peptide Aldehyde Inhibitors of Cathepsin K Inhibit Bone Resorption Both In Vitro and In Vivo
- Entropy—enthalpy compensation: Fact or artifact?